Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins

Genomics

Volumn 79, Issue 3, 2002, Pages 315-325

  Dron, Michel ^a   Meritet, Jean François ^a   Dandoy Dron, Françoise ^a   Meyniel, Jean Philippe ^a   Maury, Chantal ^a   Tovey, Michael G ^a  

^a INSTITUT ANDRÉ LWOFF   (France)

Author keywords

ATP; Gene; IFN induced; mRNA; Torsin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA INTERFERON; CHAPERONE; GAMMA INTERFERON; HYBRID PROTEIN; INTERFERON; MAGNESIUM; MESSENGER RNA; PROTEIN ADIR; TORSIN A; TORSIN B; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CHROMOSOME 1Q; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; ENDOPLASMIC RETICULUM; EXON; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; MOLECULAR CLONING; MOUSE; MOUTH CAVITY; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; SPLEEN;

ANIMALIA; ENCEPHALOMYOCARDITIS VIRUS; RODENTIA;

EID: 0036193086     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2002.6709     Document Type: Article

References (50)

1. Type I IFN modulates innate and specific antiviral immunity
2. Interferon activation and innate immunity
3. Immunomodulation and therapeutic effects of the oral use of interferon-α: Mechanism of action
4. Interferon-α induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor
5. Vanadate facilitates interferon α-mediated apoptosis that is dependent on the Jak/Stat pathway
6. Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon α: Involvement of tumor necrosis factor as ligand for the CD95 receptor
7. Cytokine therapeutics: Lessons from interferon α
8. The treatment of chronic viral hepatitis
9. Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
10. Management of multiple sclerosis
11. Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo
12. Oromucosal interferon therapy: Marked antiviral and antitumor activity
13. Oromucosal interferon therapy: Pharmacokinetics and pharmacodynamics
14. Mucosal cytokine therapy: Marked antiviral and antitumor activity
15. Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo
16. Interferon action on avian viruses. I. Oral administration of chicken interferon-α ameliorates Newcastle disease
17. Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its cDNA
18. The human interferon α species and receptors
19. The role of STATs in transcriptional control and their impact on cellular function
20. How cells respond to interferons
21. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
22. Unexpected structural requirements for GTPase activity of the interferon-induced MxA protein
23. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
24. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways
25. Characteristics of three homologous 202 genes (Ifi202α, Ifi202β, and Ifi202ψ) from the murine interferon-activatable gene 200 cluster
26. Characterization of the gene encoding the 100-kDa form of human 2′,5 oligoadenylate synthetase
27. A monomeric GTPase-negative MxA mutant with antiviral activity
28. Pathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP
29. Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions
30. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
31. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes
32. Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts
33. Cloning of a long HIV-1 readthrough transcript and detection of an increased level of early growth response protein-1 (Egr-1) mRNA in chronically infected U937 cells
34. Enhanced levels of scrapie responsive gene mRNA in BSE-infected mouse brain
35. Characterization of the human analogue of a scrapie-responsive gene
36. Mouse scrapie responsive gene 1 (Scrg1): Genomic organization, physical linkage to sap30, genetic mapping on chromosome 8, and expression in neuronal primary cell cultures
37. Distantly related sequences in the α- and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold
38. The gene (DYT1) for early-onset torsion dystonia encodes a novel protein related to the Clp protease/heat shock family
39. HSP100/Clp proteins: A common mechanism explains diverse functions
40. Cytoplasmic activation of ISGF3, the positive regulator of interferon-α-stimulated transcription, reconstituted in vitro
41. Interferon-resistant Daudi cells are deficient in interferon-α-induced ISGF3 α activation, but remain sensitive to the interferon-α-induced increase in ISGF3 γ content
42. Expression of a putative ATPase suppresses the growth defect of a yeast potassium transport mutant: Identification of a mammalian member of the Clp/HSP104 family
43. Dystonia update
44. Mutant torsin A, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells
45. Cytoplasmic activation of GAF, an IFN-γ-regulated DNA-binding factor
46. A single DNA response element can confer inducibility by both α- and γ-interferons
47. The TORIA (DYT1) gene family and its role in early onset torsion dystonia
48. Spread of symptoms in idiopathic torsion dystonia
49. Distribution of the mRNAs encoding torsin A and torsin B in the normal adult human brain
50. Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations